(Date:5/16/2008)...m an international, multicenter Phase III clinical...erapy everolimus (RAD001) significantly delays can... cancer whose disease had worsened on other treatm...attending physician at Memorial Sloan-Kettering Ca... on May 31 at the annual meeting of the American S...
(Date:5/16/2008)...ds located just beneath the lining of the uterus (...rial cavity after uterine artery embolization (UAE...rding to a new study. , The study included 49 p...mination before and after UAE. The study found tha...ted to the endometrial cavity after UAE, said Sach...
(Date:5/16/2008)... Fundraiser Seeks to Raise $38 Million for Life-th...ire-USNewswire/ -- Walkers in nearly,every state w...- May 17 and,18 -- by participating in GREAT STRID...c Fibrosis Foundation announced today., May is Na...rosis is a,life-threatening genetic disease that c...
(Date:5/16/2008)... Haag,s Statement for National HIV Vaccine Awarene...Newswire/ -- Twenty-six years into the,AIDS epidem...nutes in the,U.S. On Sunday, May 18, HIV Vaccine A...rtners in the National Institute of Allergy and In...ation Initiative, urges everyone,to help end the A...
Breaking Medicine News(10 mins):Health News:Drug fends off kidney cancer progression 2Health News:GREAT STRIDES Walks for Cystic Fibrosis Slated for 47 States This Weekend 2Health News:AIDS Action Urges Everyone to Help End the AIDS Epidemic by Being Part of the Search for an HIV Vaccine 2...ith Leukemia has urged MSPs to intervene to stop n... power lines//. The charity said that health conce...s in such areas. "It's a very clear message for t...hose Scottish people not affected want a moratoriu...
...enhanced their cooperation in the crucial area of ...ight polio and avian flu. // "The two sides disc...ideas on management of avian influenza," external ...on Navtej Sarna said. During the first meeting o...
...uy Swedish medical company Biacore to complement i...companies have announced. // The Fairfield, Conne...alises in instruments for medical research, for 3.... ($438 million). Pharmaceutical company Pfizer I...
...alarial deaths in Jharkhand's Sahibganj district, ...-led NDA // , today urged the health department to...artment should at the earliest direct its medical ... Sahibganj due to malaria and the disease has affl...
Other Medicine News:(Date:5/15/2008)...table Tolerability Profile, with Low I...AKE, N.J., May 15 /- The investigatio...9) demonstrated activity in a,heavily pretreated p...atic,breast cancer, according to results of a mult...uggests that eribulin mesylate has a manageable,to...
(Date:5/15/2008)...ks, Hispanics/Latinos, People wit...., May 15 /- Daiichi Sankyo, Inc.,an...Society of,Hypertension,s Twenty- Third Annual Sci...ated that the powerful combination drug AZOR(TM),(...fectively helped,patients across several major sub...
(Date:5/15/2008).../ -- Ergonex Pharma today,announced that the Unite...anted orphan drug designation to Terguride for the...). Terguride is currently being evaluated for PAH,...s grant of orphan drug designation to Terguride fo...rogram by offering regulatory,clinical developmen...
(Date:5/15/2008)...atelet Therapy that, Combined, with Aspirin, Cause...over and Aspirin, According to a New Report fr...Newswire/ -- Decision Resources, one of the,world,...utical and,healthcare issues, finds that Daiichi S...tient compared to Sanofi-Aventis/Bristol Myers Squ...
Breaking Medicine Technology:Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 2Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 2Daiichi Sankyo/Eli Lilly's Effient and Astrazeneca's Ticagrelor May Offer Advantages in the Treatment of Post-Myocardial Infarction 3AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune 1562 1AstraZeneca Bolsters Its Worldwide Biologics Division Through Integration of Cambridge Antibody Technology Into MedImmune 1562 2MedImmune Presents New Pharmaco Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV 688 1MedImmune Presents New Pharmaco Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV 688 2MedImmune Presents New Pharmaco Economic Data at American Academy of Pediatrics Regarding Infants at High Risk for RSV 688 3Over one third of former American football players had sexual relations with men study says 4831 1Over one third of former American football players had sexual relations with men study says 4831 2Over one third of former American football players had sexual relations with men study says 4831 3Researchers find origin of breathable atmosphere half a billion years ago 1002 1Researchers find origin of breathable atmosphere half a billion years ago 1002 2Researchers find origin of breathable atmosphere half a billion years ago 1002 3Researchers find origin of breathable atmosphere half a billion years ago 1002 4...rch 26, 2007 /PRNewswire-FirstCall/ --,Alfacell Co...ts,demonstrating the potential of ONCONASE (ranpir...cer (NSCLC) were recently,published in Anticancer ... of Intae Lee, Ph.D., at the University of,Pennsyl... Cytotoxic,RNase, Ranpirnase, on A549 Human Lung C...
...WIRE)--Mar 26, 2007 - Inovio Biomedical Corp.,(AME... vaccines and,a novel solid tumor ablation therapy... published a scientific paper prepared by,Inovio,s...m a,non-human primate study of an investigational ...medical,s electroporation technology.,The paper, t...
Other Medicine Technology:In vivo Study Results Demonstrating Potential of Alfacell's,Onconase for Treatment of Non-Small Cell Lung Cancer Published in,Anticancer Research 2In vivo Study Results Demonstrating Potential of Alfacell's,Onconase for Treatment of Non-Small Cell Lung Cancer Published in,Anticancer Research 3Inovio Biomedical's DNA Delivery Technology Significantly Enhances,Potency of HIV DNA Vaccine 2Inovio Biomedical's DNA Delivery Technology Significantly Enhances,Potency of HIV DNA Vaccine 3Inovio Biomedical's DNA Delivery Technology Significantly Enhances,Potency of HIV DNA Vaccine 4...3 mm is a resorbable repair device used in conjunc...ng device to attach soft tissue to bone using sutu... a prepared hole in the bone, and is used to attac... a resorbable copolymer, derived from glycolide an...
This type of anchor is generally used when anchor size may be an issue. This 2.9mm anchor is packaged sterile and comes pre-loaded with sutures (1-0 or 2-0) and needles. Although pre-drilling is not
...ile Anchor is a nonabsorbable repair device to att...is implanted into a prepared hole in the bone and ...rs are manufactured from Titanium (6AL4V ELI) allo...e coated with Titanium Nitride (TiN) which conform...
The MINI-TAG™ instrument systems are indicated for ulnar collateral ligament repair, scapholunate dissolution, flexor avulsions, and carpometa-carpal arthroplasty.
Medicine Products: